NCT00832689已完成2 期
Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 39
- 试验地点
- 1
研究概览
简要总结
The study hypothesis is that chemotherapy of irinotecan and gemcitabine will improve local control of cancer and prolong survival in patients with inoperable biliary tract cancer.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 17 Years 至 75 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Histologically or cytologically confirmed inoperable biliary tract cancer
- •Age: 18 ~75 years old
- •Performance status: ECOG 0-2
- •Hematopoietic:
- •Granulocyte count at least 1,500/mm3
- •Platelet count at least 100,000/mm3
- •Bilirubin No greater than 2 fold the upper normal limit
- •AST/ALT : No greater than 3 fold the upper normal limit
- •Creatinine - no greater than 1.5 mg/dL
- •Not pregnant
- •No other serious medical or psychiatric illness that would preclude giving informed consent or limit
- •No prior chemotherapy within 6 months
- •No other concurrent anticancer radiotherapy within 6 months
排除标准
- 未提供
研究组 & 干预措施
1
Experimental
干预措施: Irinotecan and Gemcitabine (Drug)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic CancerPancreatic CancerNCT00192712Rambam Health Care Campus20
已完成
2 期
Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung CancerLung CancerNCT00182806Roswell Park Cancer Institute38
已完成
2 期
Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney CancerKidney CancerNCT00401128The Cleveland Clinic9
已完成
1 期
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal CancerExtrahepatic Bile Duct CancerGallbladder CancerSmall Intestine CancerPancreatic CancerGastric CancerNCT00544193City of Hope Medical Center16
已完成
2 期
Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown PrimaryCarcinoma of Unknown PrimaryNCT00066781Alliance for Clinical Trials in Oncology31